David Sparling to Orbital Diseases
This is a "connection" page, showing publications David Sparling has written about Orbital Diseases.
Connection Strength
0.244
-
Use of Expanded Access Fosmanogepix in Two Pediatric Patients With Rhino-Orbital-Cerebral Mucormycosis. Pharmacotherapy. 2026 Sep; 46(9):e70195.
Score: 0.244
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.